{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:19:36Z","timestamp":1792703976652,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05476-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:32:35Z","timestamp":1779431555000},"page":"16757-16773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ceramide signaling in non-small-cell lung cancer: from dysregulation to targeted therapy"],"prefix":"10.1007","volume":"399","author":[{"given":"Durgesh N.","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushwant S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"5476_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080725","volume":"14","author":"IM Abdulbaqi","year":"2021","unstructured":"Abdulbaqi IM, Assi RA, Yaghmur A et al (2021) Pulmonary delivery of anticancer drugs via lipid-based nanocarriers for the treatment of lung cancer: an update. Pharmaceuticals (Basel) 14:725. https:\/\/doi.org\/10.3390\/ph14080725","journal-title":"Pharmaceuticals (Basel)"},{"key":"5476_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/IMM.70045","volume":"177","author":"S Ahuja","year":"2025","unstructured":"Ahuja S, Zaheer S (2025) Molecular mediators of metabolic reprogramming in cancer: mechanisms, regulatory networks, and therapeutic strategies. Immunology 177:1\u201343. https:\/\/doi.org\/10.1111\/IMM.70045","journal-title":"Immunology"},{"issue":"5","key":"5476_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02680-x","volume":"42","author":"M Alavinejad","year":"2025","unstructured":"Alavinejad M, Shirzad M, Javid-Naderi MJ et al (2025) Smart nanomedicines powered by artificial intelligence: a breakthrough in lung cancer diagnosis and treatment. Med Oncol 42(5):42:134-. https:\/\/doi.org\/10.1007\/s12032-025-02680-x","journal-title":"Med Oncol"},{"key":"5476_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCB.2023.151337","volume":"102","author":"J Alizadeh","year":"2023","unstructured":"Alizadeh J, da Silva Rosa SC, Weng X et al (2023) Ceramides and ceramide synthases in cancer: focus on apoptosis and autophagy. Eur J Cell Biol 102:151337. https:\/\/doi.org\/10.1016\/J.EJCB.2023.151337","journal-title":"Eur J Cell Biol"},{"key":"5476_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2022.07.001","volume":"189","author":"S Arora","year":"2022","unstructured":"Arora S, Singh P, Tabassum G et al (2022) miR-495\u20133p regulates sphingolipid metabolic reprogramming to induce Sphk1\/ceramide mediated mitophagy and apoptosis in NSCLC. Free Radic Biol Med 189:71\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.07.001","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"5476_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/S12964-025-02410-W","volume":"23","author":"S Bharadwaj","year":"2025","unstructured":"Bharadwaj S, Mierzwicka JM, Va\u0148kov\u00e1 L, Mal\u00fd P (2025) Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer. Cell Commun Signal 23(1):23:400-. https:\/\/doi.org\/10.1186\/S12964-025-02410-W","journal-title":"Cell Commun Signal"},{"key":"5476_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104472","volume":"26","author":"AU B\u0142achnio-Zabielska","year":"2025","unstructured":"B\u0142achnio-Zabielska AU, Sadowska P, Chlabicz U et al (2025) Differential effects of sphingolipids on cell death and antioxidant defenses in type 1 and type 2 endometrial cancer cells. Int J Mol Sci 26:4472. https:\/\/doi.org\/10.3390\/ijms26104472","journal-title":"Int J Mol Sci"},{"key":"5476_CR8","doi-asserted-by":"publisher","first-page":"1611929","DOI":"10.3389\/PORE.2024.1611929","volume":"30","author":"L B\u0171di","year":"2024","unstructured":"B\u0171di L, Hammer D, Varga R et al (2024) Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer. Pathology and Oncology Research 30:1611929. https:\/\/doi.org\/10.3389\/PORE.2024.1611929","journal-title":"Pathology and Oncology Research"},{"issue":"10","key":"5476_CR9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS\u2013STING pathway of cytosolic DNA sensing. Nat Immunol 17(10):1142\u20131149. https:\/\/doi.org\/10.1038\/ni.3558","journal-title":"Nat Immunol"},{"key":"5476_CR10","doi-asserted-by":"publisher","DOI":"10.62347\/AOGP2839","volume":"14","author":"L Dai","year":"2024","unstructured":"Dai L, Goyal N, Liu J (2024) Developing new ceramide analogs against non-small cell lung cancer (NSCLC). Am J Cancer Res 14:86. https:\/\/doi.org\/10.62347\/AOGP2839","journal-title":"Am J Cancer Res"},{"key":"5476_CR11","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1016\/J.BBAMCR.2014.12.039","volume":"1853","author":"M Dany","year":"2015","unstructured":"Dany M, Ogretmen B (2015) Ceramide induced mitophagy and tumor suppression. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research 1853:2834\u20132845. https:\/\/doi.org\/10.1016\/J.BBAMCR.2014.12.039","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"5476_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2174\/156800912801784811","volume":"12","author":"AR de Molina","year":"2012","unstructured":"de Molina AR, de la Cueva A, Machado-Pinilla R et al (2012) Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase \u03b1 inhibition. Curr Cancer Drug Targets 12:617\u2013624. https:\/\/doi.org\/10.2174\/156800912801784811","journal-title":"Curr Cancer Drug Targets"},{"key":"5476_CR13","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/JID.2013.153","volume":"133","author":"KM Eckl","year":"2013","unstructured":"Eckl KM, Tidhar R, Thiele H et al (2013) Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermatol 133:2202\u20132211. https:\/\/doi.org\/10.1038\/JID.2013.153","journal-title":"J Invest Dermatol"},{"issue":"1","key":"5476_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06650-y","volume":"9","author":"B Fekry","year":"2018","unstructured":"Fekry B, Jeffries KA, Esmaeilniakooshkghazi A et al (2018) C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nat Commun 9(1):9:4149-. https:\/\/doi.org\/10.1038\/s41467-018-06650-y","journal-title":"Nat Commun"},{"key":"5476_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELLSIG.2020.109838","volume":"78","author":"KH Fisher-Wellman","year":"2021","unstructured":"Fisher-Wellman KH, Hagen JT, Neufer PD et al (2021) On the nature of ceramide-mitochondria interactions \u2013 dissection using comprehensive mitochondrial phenotyping. Cell Signal 78:109838. https:\/\/doi.org\/10.1016\/J.CELLSIG.2020.109838","journal-title":"Cell Signal"},{"issue":"1","key":"5476_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58312-5","volume":"16","author":"X Fu","year":"2025","unstructured":"Fu X, Shi Y, Wu H et al (2025) Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer. Nat Commun 16(1):16:3336-. https:\/\/doi.org\/10.1038\/s41467-025-58312-5","journal-title":"Nat Commun"},{"issue":"3","key":"5476_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/S10555-011-9304-1","volume":"30","author":"H Furuya","year":"2011","unstructured":"Furuya H, Shimizu Y, Kawamori T (2011) Sphingolipids in cancer. Cancer Metastasis Rev 30(3):567\u2013576. https:\/\/doi.org\/10.1007\/S10555-011-9304-1","journal-title":"Cancer Metastasis Rev"},{"key":"5476_CR18","doi-asserted-by":"publisher","unstructured":"Gandhi S, Roy I (2023) Lipid-based inhalable micro- and nanocarriers of active agents for treating non-small-cell lung cancer. Pharmaceutics 15. https:\/\/doi.org\/10.3390\/pharmaceutics15051457","DOI":"10.3390\/pharmaceutics15051457"},{"key":"5476_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CELLSIG.2010.08.001","volume":"23","author":"P Gangoiti","year":"2011","unstructured":"Gangoiti P, Arana L, Ouro A et al (2011) Activation of mTOR and RhoA is a major mechanism by which ceramide 1-phosphate stimulates macrophage proliferation. Cell Signal 23:27\u201334. https:\/\/doi.org\/10.1016\/J.CELLSIG.2010.08.001","journal-title":"Cell Signal"},{"issue":"11","key":"5476_CR20","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao H, Korn JM, Ferretti S et al (2015) High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med 21(11):1318\u20131325. https:\/\/doi.org\/10.1038\/nm.3954","journal-title":"Nat Med"},{"issue":"7","key":"5476_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/MEDICINA57070729","volume":"57","author":"A Gomez-Larrauri","year":"2021","unstructured":"Gomez-Larrauri A, Adhikari UD, Aramburu-Nu\u00f1ez M et al (2021a) Ceramide metabolism enzymes\u2014therapeutic targets against cancer. Medicina 57(7):57:729. https:\/\/doi.org\/10.3390\/MEDICINA57070729","journal-title":"Medicina"},{"key":"5476_CR22","doi-asserted-by":"publisher","unstructured":"Gomez-Larrauri A, Ouro A, Trueba M, Gomez-Mu\u00f1oz A (2021b) Regulation of cell growth, survival and migration by ceramide 1-phosphate - implications in lung cancer progression and inflammation. Cell Signal 83. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109980","DOI":"10.1016\/j.cellsig.2021.109980"},{"key":"5476_CR23","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/J.BBAMEM.2006.08.012","volume":"1758","author":"V Gouaze-Andersson","year":"2006","unstructured":"Gouaze-Andersson V, Cabot MC (2006) Glycosphingolipids and drug resistance. Biochimica Et Biophysica Acta (BBA) - Biomembranes 1758:2096\u20132103. https:\/\/doi.org\/10.1016\/J.BBAMEM.2006.08.012","journal-title":"Biochimica Et Biophysica Acta (BBA) - Biomembranes"},{"key":"5476_CR24","doi-asserted-by":"publisher","first-page":"17402","DOI":"10.1073\/pnas.0802781105","volume":"105","author":"GG Guenther","year":"2008","unstructured":"Guenther GG, Peralta ER, Rosales KR et al (2008) Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc Natl Acad Sci U S A 105:17402\u201317407. https:\/\/doi.org\/10.1073\/pnas.0802781105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5476_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1043-6618(03)00052-5","volume":"47","author":"E Gulbins","year":"2003","unstructured":"Gulbins E (2003) Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47:393\u2013399. https:\/\/doi.org\/10.1016\/S1043-6618(03)00052-5","journal-title":"Pharmacol Res"},{"key":"5476_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/J.CELL.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/J.CELL.2011.02.013","journal-title":"Cell"},{"key":"5476_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139\u2013150. https:\/\/doi.org\/10.1038\/nrm2329","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5476_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/J.BIOCEL.2011.12.019","volume":"44","author":"D Hartmann","year":"2012","unstructured":"Hartmann D, Lucks J, Fuchs S et al (2012) Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol 44:620\u2013628. https:\/\/doi.org\/10.1016\/J.BIOCEL.2011.12.019","journal-title":"Int J Biochem Cell Biol"},{"key":"5476_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/NATURE25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553:446\u2013454. https:\/\/doi.org\/10.1038\/NATURE25183","journal-title":"Nature"},{"key":"5476_CR30","doi-asserted-by":"publisher","unstructured":"Holder JE, Ferguson C, Oliveira E, et al (2023) The use of nanoparticles for targeted drug delivery in non-small cell lung cancer. Front Oncol 13. https:\/\/doi.org\/10.3389\/fonc.2023.1154318","DOI":"10.3389\/fonc.2023.1154318"},{"key":"5476_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/565316","volume":"2011","author":"W-C Huang","year":"2011","unstructured":"Huang W-C, Chen C-L, Lin Y-S, Lin C-F (2011) Apoptotic sphingolipid ceramide in cancer therapy. J Lipids 2011:565316. https:\/\/doi.org\/10.1155\/2011\/565316","journal-title":"J Lipids"},{"key":"5476_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/BS.ACR.2018.04.011","volume":"140","author":"KA Jeffries","year":"2018","unstructured":"Jeffries KA, Krupenko NI (2018) Ceramide signaling and p53 pathways. Adv Cancer Res 140:191\u2013215. https:\/\/doi.org\/10.1016\/BS.ACR.2018.04.011","journal-title":"Adv Cancer Res"},{"key":"5476_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/J.BBALIP.2013.09.005","volume":"1841","author":"W Jiang","year":"2014","unstructured":"Jiang W, Ogretmen B (2014) Autophagy paradox and ceramide. Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1841:783\u2013792. https:\/\/doi.org\/10.1016\/J.BBALIP.2013.09.005","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"5476_CR34","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-16-3313","volume":"77","author":"K Kachler","year":"2017","unstructured":"Kachler K, Bailer M, Heim L et al (2017) Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non-small cell lung carcinoma. Cancer Res 77:5963\u20135976. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3313","journal-title":"Cancer Res"},{"key":"5476_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1515\/hsz-2015-0129","volume":"396","author":"M Kester","year":"2015","unstructured":"Kester M, Bassler J, Fox TE et al (2015) Preclinical development of a C6-ceramide nanoliposome, a novel sphingolipid therapeutic. Biol Chem 396:737\u2013747. https:\/\/doi.org\/10.1515\/hsz-2015-0129","journal-title":"Biol Chem"},{"key":"5476_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1535-7163.MCT-19-0366","volume":"19","author":"SK Khiste","year":"2020","unstructured":"Khiste SK, Liu Z, Roy KR et al (2020) Ceramide-rubusoside nanomicelles, a potential therapeutic approach to target cancers carrying p53 missense mutations. Mol Cancer Ther 19:564\u2013574. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-0366","journal-title":"Mol Cancer Ther"},{"key":"5476_CR37","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1111\/cas.14171","volume":"110","author":"K Kita","year":"2019","unstructured":"Kita K, Fukuda K, Takahashi H et al (2019) Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance. Cancer Sci 110:3215. https:\/\/doi.org\/10.1111\/cas.14171","journal-title":"Cancer Sci"},{"issue":"1","key":"5476_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2019","unstructured":"Koundouros N, Poulogiannis G (2019) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122(1):4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J Cancer"},{"key":"5476_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.MOLMED.2018.10.009","volume":"25","author":"J Kurz","year":"2019","unstructured":"Kurz J, Parnham MJ, Geisslinger G, Schiffmann S (2019) Ceramides as novel disease biomarkers. Trends Mol Med 25:20\u201332. https:\/\/doi.org\/10.1016\/J.MOLMED.2018.10.009","journal-title":"Trends Mol Med"},{"issue":"1","key":"5476_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57028-8","volume":"14","author":"S La Monica","year":"2024","unstructured":"La Monica S, Vacondio F, Eltayeb K et al (2024) Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models. Sci Rep 14(1):6491. https:\/\/doi.org\/10.1038\/s41598-024-57028-8","journal-title":"Sci Rep"},{"key":"5476_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1389200216666151103120338","volume":"17","author":"F Li","year":"2015","unstructured":"Li F, Zhang N (2015) Ceramide: therapeutic potential in combination therapy for cancer treatment. Curr Drug Metab 17:37\u201351. https:\/\/doi.org\/10.2174\/1389200216666151103120338","journal-title":"Curr Drug Metab"},{"key":"5476_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941643","volume":"12","author":"RZ Li","year":"2022","unstructured":"Li RZ, Wang XR, Wang J et al (2022) The key role of sphingolipid metabolism in cancer: new therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance. Front Oncol 12:941643. https:\/\/doi.org\/10.3389\/fonc.2022.941643","journal-title":"Front Oncol"},{"key":"5476_CR43","doi-asserted-by":"publisher","unstructured":"Li J, Hu J, Yang Y et al (2025) Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Mol Biomed 6(1):111. https:\/\/doi.org\/10.1186\/S43556-025-00352-W","DOI":"10.1186\/S43556-025-00352-W"},{"issue":"1","key":"5476_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/S12964-024-01957-4","volume":"22","author":"M Liaghat","year":"2024","unstructured":"Liaghat M, Ferdousmakan S, Mortazavi SH et al (2024) The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors. Cell Commun Signal 22(1):575. https:\/\/doi.org\/10.1186\/S12964-024-01957-4","journal-title":"Cell Commun Signal"},{"key":"5476_CR45","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1074\/jbc.274.2.1140","volume":"274","author":"YY Liu","year":"1999","unstructured":"Liu YY, Han TY, Giuliano AE, Cabot MC (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274:1140\u20131146. https:\/\/doi.org\/10.1074\/jbc.274.2.1140","journal-title":"J Biol Chem"},{"key":"5476_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4155\/FMC.13.107","volume":"5","author":"J Liu","year":"2013","unstructured":"Liu J, Beckman BS, Foroozesh M (2013a) A review of ceramide analogs as potential anticancer agents. Future Med Chem 5:1405\u20131421. https:\/\/doi.org\/10.4155\/FMC.13.107","journal-title":"Future Med Chem"},{"key":"5476_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-394274-6.00003-0","volume":"117","author":"YY Liu","year":"2013","unstructured":"Liu YY, Hill RA, Li YT (2013b) Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv Cancer Res 117:59\u201389. https:\/\/doi.org\/10.1016\/B978-0-12-394274-6.00003-0","journal-title":"Adv Cancer Res"},{"key":"5476_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6730504","volume":"2024","author":"M Lv","year":"2024","unstructured":"Lv M, Shao S, Du Y et al (2024) Plasma lipidomics profiling to identify the biomarkers of diagnosis and radiotherapy response for advanced non-small-cell lung cancer patients. J Lipids 2024:6730504. https:\/\/doi.org\/10.1155\/2024\/6730504","journal-title":"J Lipids"},{"key":"5476_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.PCCM.2025.05.002","volume":"3","author":"C Mao","year":"2025","unstructured":"Mao C (2025) Sphingolipid metabolism dysregulation: a cause for lung cancer development, progression, and resistance to therapies. Chin Med J Pulm Crit Care Med 3:88\u201396. https:\/\/doi.org\/10.1016\/J.PCCM.2025.05.002","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"5476_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P (2024) Metabolic reprogramming, sensing, and cancer therapy. Cell Rep 43:115064. https:\/\/doi.org\/10.1016\/J.CELREP.2024.115064","journal-title":"Cell Rep"},{"key":"5476_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1548655","volume":"12","author":"J Mao","year":"2025","unstructured":"Mao J, Li L, Sun H et al (2025) Investigation of sphingolipid-related genes in lung adenocarcinoma. Front Mol Biosci 12:1548655. https:\/\/doi.org\/10.3389\/fmolb.2025.1548655","journal-title":"Front Mol Biosci"},{"key":"5476_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/NRC3398","volume":"13","author":"SAF Morad","year":"2013","unstructured":"Morad SAF, Cabot MC (2013) Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13:51\u201365. https:\/\/doi.org\/10.1038\/NRC3398","journal-title":"Nat Rev Cancer"},{"key":"5476_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/ESMOOPEN-2016-000060","volume":"1","author":"F Morgillo","year":"2016","unstructured":"Morgillo F, Della Corte CM, Fasano M, Ciardiello F (2016) Mechanisms of resistance to EGFR-targeted drugs: lung cancer. ESMO Open 1:e000060. https:\/\/doi.org\/10.1136\/ESMOOPEN-2016-000060","journal-title":"ESMO Open"},{"issue":"4","key":"5476_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/S12282-019-00953-8","volume":"26","author":"K Moro","year":"2019","unstructured":"Moro K, Nagahashi M, Gabriel E et al (2019) Clinical application of ceramide in cancer treatment. Breast Cancer 26(4):407\u2013415. https:\/\/doi.org\/10.1007\/S12282-019-00953-8","journal-title":"Breast Cancer"},{"issue":"11","key":"5476_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS26115112","volume":"26","author":"MS Mostaq","year":"2025","unstructured":"Mostaq MS, Kang L, Patwardhan GA et al (2025) Glucosylceramide synthase, a key enzyme in sphingolipid metabolism, regulates expression of genes accounting for cancer drug resistance. Int J Mol Sci 26(11):5112. https:\/\/doi.org\/10.3390\/IJMS26115112","journal-title":"Int J Mol Sci"},{"key":"5476_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jgg.2023.06.006","volume":"51","author":"J Mu","year":"2024","unstructured":"Mu J, Lam SM, Shui G (2024) Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity. J Genet Genomics 51:268\u2013278. https:\/\/doi.org\/10.1016\/j.jgg.2023.06.006","journal-title":"J Genet Genomics"},{"key":"5476_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B (2018) Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer 18:33\u201350. https:\/\/doi.org\/10.1038\/nrc.2017.96","journal-title":"Nat Rev Cancer"},{"key":"5476_CR58","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/J.GENDIS.2022.07.023","volume":"10","author":"H Padinharayil","year":"2023","unstructured":"Padinharayil H, Varghese J, John MC et al (2023) Non-small cell lung carcinoma (NSCLC): implications on molecular pathology and advances in early diagnostics and therapeutics. Genes Dis 10:960\u2013989. https:\/\/doi.org\/10.1016\/J.GENDIS.2022.07.023","journal-title":"Genes Dis"},{"key":"5476_CR59","doi-asserted-by":"publisher","unstructured":"Pant DC, Aguilera-Albesa S, Pujol A (2020) Ceramide signalling in inherited and multifactorial brain metabolic diseases. Neurobiol Dis 143:105014. https:\/\/doi.org\/10.1016\/J.NBD.2020.105014","DOI":"10.1016\/J.NBD.2020.105014"},{"key":"5476_CR60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4161\/AUTO.5.4.8390","volume":"5","author":"S Pattingre","year":"2009","unstructured":"Pattingre S, Bauvy C, Levade T et al (2009) Ceramide-induced autophagy: to junk or to protect cells? Autophagy 5:558\u2013560. https:\/\/doi.org\/10.4161\/AUTO.5.4.8390","journal-title":"Autophagy"},{"issue":"2","key":"5476_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/S10863-015-9602-3","volume":"48","author":"GA Patwardhan","year":"2015","unstructured":"Patwardhan GA, Beverly LJ, Siskind LJ (2015) Sphingolipids and mitochondrial apoptosis. J Bioenerg Biomembr 48(2):153\u2013168. https:\/\/doi.org\/10.1007\/S10863-015-9602-3","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"5476_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s43094-025-00816-4","volume":"11","author":"SM Pawar","year":"2025","unstructured":"Pawar SM, Chitre T, Dandawate P (2025) Acid ceramidase-1 (ASAH1\/aCDase) an important for anticancer drug discovery: a review. Future J Pharm Sci 11(1):58. https:\/\/doi.org\/10.1186\/s43094-025-00816-4","journal-title":"Future J Pharm Sci"},{"key":"5476_CR63","doi-asserted-by":"publisher","first-page":"10911","DOI":"10.1074\/JBC.M109.077610","volume":"285","author":"Y Pewzner-Jung","year":"2010","unstructured":"Pewzner-Jung Y, Brenner O, Braun S et al (2010) A critical role for ceramide synthase 2 in liver homeostasis: ii. insights into molecular changes leading to hepatopathy. J Biol Chem 285:10911\u201310923. https:\/\/doi.org\/10.1074\/JBC.M109.077610","journal-title":"J Biol Chem"},{"key":"5476_CR64","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2217\/FON.10.116","volume":"6","author":"S Ponnusamy","year":"2010","unstructured":"Ponnusamy S, Meyers-Needham M, Senkal CE et al (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol 6:1603\u20131624. https:\/\/doi.org\/10.2217\/FON.10.116","journal-title":"Future Oncol"},{"key":"5476_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/01902148.2020.1844345","volume":"47","author":"H Qian","year":"2021","unstructured":"Qian H, Deng J, Lu C et al (2021) Ceramide synthases: insights into the expression and prognosis of lung cancer. Exp Lung Res 47:37\u201353. https:\/\/doi.org\/10.1080\/01902148.2020.1844345","journal-title":"Exp Lung Res"},{"key":"5476_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, Lu Y et al (2020) Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 5:228. https:\/\/doi.org\/10.1038\/s41392-020-00313-5","journal-title":"Signal Transduct Target Ther"},{"key":"5476_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22115793","volume":"22","author":"BM Quinville","year":"2021","unstructured":"Quinville BM, Deschenes NM, Ryckman AE, Walia JS (2021) A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis. Int J Mol Sci 22:5793. https:\/\/doi.org\/10.3390\/IJMS22115793","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5476_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","volume":"22","author":"Z Rahal","year":"2025","unstructured":"Rahal Z, El Darzi R, Moghaddam SJ et al (2025) Tumour and microenvironment crosstalk in NSCLC progression and response to therapy. Nat Rev Clin Oncol 22(7):463\u2013482. https:\/\/doi.org\/10.1038\/s41571-025-01021-1","journal-title":"Nat Rev Clin Oncol"},{"key":"5476_CR69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","volume":"206","author":"CP Reynolds","year":"2004","unstructured":"Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169\u2013180. https:\/\/doi.org\/10.1016\/j.canlet.2003.08.034","journal-title":"Cancer Lett"},{"key":"5476_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17080996","volume":"17","author":"I Safdar","year":"2025","unstructured":"Safdar I, Mahmood S, Abdulwahab MK et al (2025) Inhalable nanomaterial discoveries for lung cancer therapy: a review. Pharmaceutics 17:996. https:\/\/doi.org\/10.3390\/pharmaceutics17080996","journal-title":"Pharmaceutics"},{"key":"5476_CR71","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/J.BBALIP.2012.04.008","volume":"1821","author":"T Sassa","year":"2012","unstructured":"Sassa T, Suto S, Okayasu Y, Kihara A (2012) A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells. Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:1031\u20131037. https:\/\/doi.org\/10.1016\/J.BBALIP.2012.04.008","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"5476_CR72","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1074\/jbc.M313561200","volume":"279","author":"F Scarlatti","year":"2004","unstructured":"Scarlatti F, Bauvy C, Ventruti A et al (2004) Ceramide-mediated macroautophagy involves inhibition of protein kinase b and up-regulation of beclin 1. J Biol Chem 279:18384\u201318391. https:\/\/doi.org\/10.1074\/jbc.M313561200","journal-title":"J Biol Chem"},{"key":"5476_CR73","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1158\/1535-7163.MCT-06-0558","volume":"6","author":"CE Senkal","year":"2007","unstructured":"Senkal CE, Ponnusamy S, Rossi MJ et al (2007) Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 6:712\u2013722. https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0558","journal-title":"Mol Cancer Ther"},{"key":"5476_CR74","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1096\/FJ.09-135087","volume":"24","author":"CE Senkal","year":"2010","unstructured":"Senkal CE, Ponnusamy S, Bielawski J et al (2010) Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6\/ CHOP arm of ER-stress-response pathways. FASEB J 24:296\u2013308. https:\/\/doi.org\/10.1096\/FJ.09-135087","journal-title":"FASEB J"},{"key":"5476_CR75","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nchembio.1059","volume":"8","author":"RD Sentelle","year":"2012","unstructured":"Sentelle RD, Senkal CE, Jiang W et al (2012) Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol 8:831. https:\/\/doi.org\/10.1038\/nchembio.1059","journal-title":"Nat Chem Biol"},{"key":"5476_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126671","volume":"23","author":"D Sharma","year":"2022","unstructured":"Sharma D, Czarnota GJ (2022) Involvement of ceramide signalling in radiation-induced tumour vascular effects and vascular-targeted therapy. Int J Mol Sci 23:6671. https:\/\/doi.org\/10.3390\/ijms23126671","journal-title":"Int J Mol Sci"},{"key":"5476_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS13102475","volume":"13","author":"M Sheridan","year":"2021","unstructured":"Sheridan M, Ogretmen B (2021) The role of ceramide metabolism and signaling in the regulation of mitophagy and cancer therapy. Cancers 13:2475. https:\/\/doi.org\/10.3390\/CANCERS13102475","journal-title":"Cancers"},{"key":"5476_CR78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3892\/ijmm.2021.4918","volume":"47","author":"Y Shi","year":"2021","unstructured":"Shi Y, Jin Y, Liu F et al (2021) Ceramide induces the apoptosis of non-small cell lung cancer cells through the Txnip\/Trx1 complex. Int J Mol Med 47:85. https:\/\/doi.org\/10.3892\/ijmm.2021.4918","journal-title":"Int J Mol Med"},{"issue":"3","key":"5476_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/S10863-005-6567-7","volume":"37","author":"LJ Siskind","year":"2005","unstructured":"Siskind LJ (2005) Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr 37(3):143\u2013153. https:\/\/doi.org\/10.1007\/S10863-005-6567-7","journal-title":"J Bioenerg Biomembr"},{"key":"5476_CR80","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1158\/1078-0432.CCR-10-0720","volume":"17","author":"L Song","year":"2011","unstructured":"Song L, Xiong H, Li J et al (2011) Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K\/Akt\/NF-\u03baB pathway in human non-small cell lung cancer. Clin Cancer Res 17:1839\u20131849. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-0720","journal-title":"Clin Cancer Res"},{"key":"5476_CR81","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41586-024-07787-1","volume":"633","author":"M Soula","year":"2024","unstructured":"Soula M, Unlu G, Welch R et al (2024) Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer. Nature 633:451\u2013458. https:\/\/doi.org\/10.1038\/s41586-024-07787-1","journal-title":"Nature"},{"key":"5476_CR82","doi-asserted-by":"publisher","unstructured":"Summers SA, Chaurasia B, Holland WL (2019) Metabolic Messengers: ceramides. Nat Metab 1(11) 1051\u20131058. https:\/\/doi.org\/10.1038\/s42255-019-0134-8","DOI":"10.1038\/s42255-019-0134-8"},{"key":"5476_CR83","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/14728222.2017.1322065","volume":"21","author":"SF Tan","year":"2017","unstructured":"Tan SF, Pearson JM, Feith DJ, Loughran TP (2017) The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia. Expert Opin Ther Targets 21:583. https:\/\/doi.org\/10.1080\/14728222.2017.1322065","journal-title":"Expert Opin Ther Targets"},{"key":"5476_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/MOG2.70009","volume":"4","author":"Y Tan","year":"2025","unstructured":"Tan Y, Qin S, Zhang Z et al (2025) Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies. MedComm Oncol 4:e70009. https:\/\/doi.org\/10.1002\/MOG2.70009","journal-title":"MedComm Oncol"},{"issue":"1","key":"5476_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/S12944-025-02642-2","volume":"24","author":"H Thakkar","year":"2025","unstructured":"Thakkar H, Vincent V, Chaurasia B (2025) Ceramide signaling in immunity: a molecular perspective. Lipids Health Dis 24(1):225-. https:\/\/doi.org\/10.1186\/S12944-025-02642-2","journal-title":"Lipids Health Dis"},{"key":"5476_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.YEXCR.2015.05.012","volume":"336","author":"A Tyler","year":"2015","unstructured":"Tyler A, Johansson A, Karlsson T et al (2015) Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells. Exp Cell Res 336:23\u201332. https:\/\/doi.org\/10.1016\/J.YEXCR.2015.05.012","journal-title":"Exp Cell Res"},{"key":"5476_CR87","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1021\/mp800030k","volume":"5","author":"LE van Vlerken","year":"2008","unstructured":"van Vlerken LE, Duan Z, Little SR et al (2008) Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model. Mol Pharm 5:516\u2013526. https:\/\/doi.org\/10.1021\/mp800030k","journal-title":"Mol Pharm"},{"key":"5476_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1208\/s12248-010-9174-4","volume":"12","author":"LE Van Vlerken","year":"2010","unstructured":"Van Vlerken LE, Duan Z, Little SR et al (2010) Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems. AAPS J 12:171\u2013180. https:\/\/doi.org\/10.1208\/s12248-010-9174-4","journal-title":"AAPS J"},{"key":"5476_CR89","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2174\/1568026619666190227222930","volume":"19","author":"Y Vijayan","year":"2019","unstructured":"Vijayan Y, Lankadasari MB, Harikumar KB (2019) Acid ceramidase: a novel therapeutic target in cancer. Curr Top Med Chem 19:1512\u20131520. https:\/\/doi.org\/10.2174\/1568026619666190227222930","journal-title":"Curr Top Med Chem"},{"key":"5476_CR90","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1038\/SJ.ONC.1205497","volume":"21","author":"C Von Haefen","year":"2002","unstructured":"Von Haefen C, Wieder T, Gillissen B et al (2002) Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21:4009\u20134019. https:\/\/doi.org\/10.1038\/SJ.ONC.1205497","journal-title":"Oncogene"},{"key":"5476_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMET.2024.101936","volume":"83","author":"N Wajapeyee","year":"2024","unstructured":"Wajapeyee N, Beamon TC, Gupta R (2024) Roles and therapeutic targeting of ceramide metabolism in cancer. Mol Metab 83:101936. https:\/\/doi.org\/10.1016\/J.MOLMET.2024.101936","journal-title":"Mol Metab"},{"key":"5476_CR92","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1080\/10717544.2016.1225853","volume":"24","author":"T Wang","year":"2017","unstructured":"Wang T, Feng L, Yang S et al (2017) Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency. Drug Deliv 24:800. https:\/\/doi.org\/10.1080\/10717544.2016.1225853","journal-title":"Drug Deliv"},{"key":"5476_CR93","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12951-021-00895-4","volume":"19","author":"H Wang","year":"2021","unstructured":"Wang H, Shi W, Zeng D et al (2021) pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer. J Nanobiotechnol 19:152. https:\/\/doi.org\/10.1186\/s12951-021-00895-4","journal-title":"J Nanobiotechnol"},{"key":"5476_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.lungcan.2021.04.007","volume":"156","author":"D Waterhouse","year":"2021","unstructured":"Waterhouse D, Lam J, Betts KA et al (2021) Real-world outcomes of immunotherapy\u2013based regimens in first-line advanced non-small cell lung cancer. Lung Cancer 156:41\u201349. https:\/\/doi.org\/10.1016\/j.lungcan.2021.04.007","journal-title":"Lung Cancer"},{"issue":"6","key":"5476_CR95","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17(6):363\u2013375. https:\/\/doi.org\/10.1038\/nri.2017.21","journal-title":"Nat Rev Immunol"},{"key":"5476_CR96","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401\u2013410. https:\/\/doi.org\/10.1038\/nrc3262","journal-title":"Nat Rev Cancer"},{"key":"5476_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15071994","volume":"15","author":"Y Xu","year":"2023","unstructured":"Xu Y, Pan J, Lin Y et al (2023) Ceramide synthase 1 inhibits brain metastasis of non-small cell lung cancer by interacting with USP14 and downregulating the PI3K\/AKT\/mTOR signaling pathway. Cancers (Basel) 15:1994. https:\/\/doi.org\/10.3390\/CANCERS15071994","journal-title":"Cancers (Basel)"},{"key":"5476_CR98","doi-asserted-by":"publisher","unstructured":"Xue Y, Jiang K, Ou L et al (2022) Targeting sphingosine kinase 1\/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth. Cell Death Dis 13. https:\/\/doi.org\/10.1038\/s41419-022-05049-4","DOI":"10.1038\/s41419-022-05049-4"},{"key":"5476_CR99","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/S10616-017-0154-8","volume":"70","author":"M Yildiz-Ozer","year":"2018","unstructured":"Yildiz-Ozer M, Oztopcu-Vatan P, Kus G (2018) The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro. Cytotechnology 70:387\u2013396. https:\/\/doi.org\/10.1007\/S10616-017-0154-8","journal-title":"Cytotechnology"},{"key":"5476_CR100","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2217\/fon.13.111","volume":"9","author":"P Zarogoulidis","year":"2013","unstructured":"Zarogoulidis P, Darwiche K, Krauss L et al (2013) Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients. Future Oncol 9:1307\u20131313. https:\/\/doi.org\/10.2217\/fon.13.111","journal-title":"Future Oncol"},{"key":"5476_CR101","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/S11095-013-1190-5","volume":"31","author":"P Zou","year":"2014","unstructured":"Zou P, Stern ST, Sun D (2014) PLGA\/liposome hybrid nanoparticles for short-chain ceramide delivery. Pharm Res 31:684\u2013693. https:\/\/doi.org\/10.1007\/S11095-013-1190-5","journal-title":"Pharm Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05476-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:02:26Z","timestamp":1787662946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05476-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5476"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05476-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No experiments on human or animal subjects were performed in this study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}